GeneDx Holdings Corp.
WGS WGSWWCIK 0001818331 · Services-Health Services · Nasdaq, Nasdaq
- Sema4 Holdings Corp. (until 2023-01-05)
- CM Life Sciences, Inc. (until 2021-07-21)
Revenue (TTM)
$408.8M
+40.0% YoY
Q1 May 2026
Net Income (TTM)
−$66.67M
+59.8% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.30
+62.4% YoY
Q1 May 2026
Gross Margin
69.0%
Q1 May 2026
Operating Margin
-13.8%
Q1 May 2026
Net Margin
-16.3%
Q1 May 2026
Free Cash Flow (TTM)
−$107.22M
Q1 May 2026
Cash
$93.92M
Q1 May 2026
Total Debt
$96.73M
Q1 May 2026
Shares Outstanding
29.69M sh
Q1 May 2026